Hypertrophic cardiomyopathy and pregnancy.
The case of a young primiparous woman with defibrillator-assisted familial hypertrophic cardiomyopathy (HCM) has led us to review the literature on this pathology, which is exceptional because of its scarcity and the originality of the problems encountered. To our knowledge, this is the first observation ever reported of defibrillator-assisted activation during pregnancy in a woman with HCM. Several questions raised from this particular case, e.g. what are the risks caused by pregnancy in these patients, what is the impact of therapeutics, does the activation of an internal defibrillator involve particular risks, what is the best disposition for delivery and what are the risks for fetuses? We have tried to ask all of these questions, using as exhaustive a literature review as possible.
Piacenza
J M
JM
Hospital Edouard Herriot, Gynecologie Obstetrique, Lyon, France.
Kirkorian
G
G
Audra
P H
PH
Mellier
G
G
D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis; D017147:Defibrillators, Implantable; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007743:Labor, Obstetric; D049590:Postpartum Period; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011379:Prognosis